BKA - Nursing Case Study

Pathophysiology

• Primary mechanism: Peripheral vascular disease leads to reduced blood flow, causing tissue ischemia and necrosis in the lower extremities, necessitating below-knee amputation (BKA).

• Secondary mechanism: Diabetes mellitus exacerbates this process by contributing to neuropathy and poor wound healing, increasing the risk of infection and gangrene.

• Key complication: Post-amputation, patients often face phantom limb pain and require rehabilitation to adapt to altered mobility and prevent further complications, such as pressure ulcers or joint contractures.

Patient Profile

Demographics:

56-year-old male, retired construction worker

History:

• Key past medical history: Type 2 Diabetes Mellitus, Peripheral Vascular Disease, Hypertension

• Current medications: Metformin, Lisinopril, Aspirin, Insulin

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Increasing pain and swelling in the residual limb post-surgery

• Key symptoms: Redness and discharge at the amputation site, intermittent fever, difficulty with mobility

• Vital signs: Temperature 38.5°C, Blood Pressure 145/95 mmHg, Heart Rate 96 bpm, Respiratory Rate 20 breaths per minute

Section 1

As the healthcare team conducts an initial assessment following the reported symptoms of increasing pain and swelling in the residual limb, further examination reveals a tender, erythematous area surrounding the amputation site, with notable purulent discharge. The wound appears to be poorly healing, with signs of possible cellulitis. The patient's elevated temperature of 38.5°C and intermittent fever suggest a systemic response to infection.

Laboratory results are obtained to guide the next steps in management. White blood cell count is elevated at 15,000/mm³, indicating a likely infectious process. C-reactive protein levels are also elevated at 12 mg/L, reinforcing the suspicion of inflammation and infection. Blood cultures are pending, but there is a high index of suspicion for a bacterial infection given the patient's immune-compromised status from diabetes and recent surgery. Given the patient's allergy to penicillin, the healthcare team begins empirical treatment with clindamycin, which covers potential pathogens while awaiting culture results.

The patient's clinical status necessitates a multidisciplinary approach, including infectious disease consultation to optimize antibiotic therapy and wound care specialists to address the local wound environment. The team also considers the need for imaging studies, such as an X-ray or MRI, to rule out osteomyelitis as a deeper complication. This situation underscores the importance of vigilant monitoring and timely intervention to prevent further deterioration and highlights the interplay between chronic conditions and post-surgical recovery. The next steps will focus on evaluating the effectiveness of the antibiotic regimen and assessing the potential need for surgical intervention to manage the infection adequately.

Section 2

As the healthcare team continues to monitor the patient’s progress, new diagnostic results provide further insight into the evolving clinical picture. Blood culture results return positive for methicillin-resistant Staphylococcus aureus (MRSA), necessitating a shift in the antibiotic regimen. Clindamycin is discontinued, and the patient is started on intravenous vancomycin, given its efficacy against MRSA and the patient's penicillin allergy. Additionally, imaging studies, including an MRI, confirm the presence of osteomyelitis extending from the poorly healing amputation site into the tibia, complicating the clinical scenario.

The patient’s status remains complicated by persistent symptoms. Vital signs reveal continued fever spikes, with temperatures reaching up to 39°C. The patient experiences increased fatigue and decreased appetite, raising concerns about overall nutrition and energy levels, which are critical for wound healing and recovery. There is also a noticeable decline in the patient's mood and engagement with the care team, possibly indicating the onset of depression or anxiety related to the prolonged recovery and potential implications of the infection.

In response to these developments, the healthcare team initiates a more aggressive approach. A surgical consultation is sought to evaluate the necessity of debridement or additional surgical interventions to manage the osteomyelitis effectively. Concurrently, the team enhances support services, including nutritional counseling to address dietary needs and psychological support to help manage the emotional burden of the situation. This multifaceted approach highlights the complexity of managing post-operative infections in patients with underlying conditions and the importance of timely, coordinated care to improve outcomes. The next steps will focus on monitoring the response to vancomycin, evaluating the need for surgical intervention, and supporting the patient's holistic well-being.

Section 3

New complications have emerged as the healthcare team closely monitors the patient's response to the current interventions. Despite the initiation of intravenous vancomycin, the patient's fever persists, with temperatures consistently ranging from 38.5°C to 39°C. Blood pressure remains stable at 120/75 mmHg, but the heart rate has increased to 105 beats per minute, suggesting a possible systemic inflammatory response. Laboratory results reveal a white blood cell count of 16,000/mm³, indicating a persistent infectious process. C-reactive protein levels also remain elevated, further confirming ongoing inflammation. These findings raise concerns about the adequacy of the current antibiotic regimen and potential complications in the management of osteomyelitis.

In addition to the laboratory indicators, the patient reports new onset of localized pain and swelling around the amputation site, with erythema extending proximally. This development prompts the team to consider the possibility of an abscess formation or further necrotic tissue requiring intervention. Given these complications, the surgical team is consulted once more to reassess the need for urgent debridement or even additional surgical procedures to address potential abscesses and halt the progression of osteomyelitis. The team also explores the potential need for an expanded antibiotic coverage or adjustment in dosing to better manage the resistant infection.

In light of these developments, the healthcare team revisits the patient's comprehensive care plan. They prioritize continuous monitoring of vital signs, pain management, and regular reassessment of the amputation site for any changes. The ongoing coordination with the surgical team, infectious disease specialists, and support services remains critical. The team also emphasizes the importance of maintaining optimal nutritional support and psychological well-being to enhance the patient's resilience and engagement in the recovery process. Moving forward, the focus will be on assessing the patient's response to any surgical interventions and further modifications of the antimicrobial strategy to mitigate the risk of additional complications.

Section 4

As the healthcare team continues to manage the patient's condition, new diagnostic results provide further insights into the evolving complications. A repeat magnetic resonance imaging (MRI) scan of the amputation site reveals a fluid collection suggestive of an abscess, located beneath the proximal erythematous area. This finding correlates with the patient's increased localized pain and swelling, confirming the suspicion of a developing abscess that may require surgical intervention. In addition to the imaging results, blood cultures obtained earlier have now revealed growth of methicillin-resistant Staphylococcus aureus (MRSA), indicating that the current antibiotic regimen may need adjustment to effectively target this pathogen.

The persistence of fever, coupled with the elevated white blood cell count and C-reactive protein levels, underscores the need for a more aggressive approach to managing the infection. Given the identification of MRSA, the infectious disease team recommends broadening the antibiotic coverage to include linezolid, alongside the current vancomycin, to enhance antimicrobial efficacy. This decision is made in collaboration with the surgical team, who are preparing for a possible debridement to address the abscess and further evaluate the extent of osteomyelitis.

As the patient navigates these complications, the healthcare team remains vigilant in monitoring vital signs and laboratory markers to assess response to the updated treatment plan. The coordination between surgical and medical teams is critical in determining the optimal timing for surgical intervention, balancing the need to control the infection with the patient’s overall stability. The focus also remains on supporting the patient's nutritional and psychological needs, recognizing that comprehensive care is essential for promoting recovery and preventing further setbacks. This integrated approach ensures that any new developments are swiftly addressed, paving the way for the next stages of the patient's healing journey.

Section 5

As the healthcare team continues to monitor the patient's response to the updated treatment regimen, a change in the patient's status is observed, providing new challenges and opportunities for clinical reasoning. Over the next 48 hours, the patient's vital signs reveal a persistent low-grade fever, with temperatures ranging from 100.4°F to 101.2°F (38°C to 38.5°C), despite the introduction of linezolid to the antibiotic regimen. Blood pressure remains stable at 120/75 mmHg, but the heart rate has increased slightly to 102 beats per minute, suggesting a possible systemic response to ongoing infection. The surgical team notes that the erythematous area around the amputation site has increased in size, with the edges becoming more indurated and tender upon palpation. The patient reports worsening pain at the site, now rated 8/10 on the pain scale, prompting the need for reassessment of pain management strategies.

Laboratory data continue to reflect the inflammatory process, with white blood cell counts peaking at 15,500/mm³ (normal range: 4,500-11,000/mm³) and C-reactive protein levels rising to 120 mg/L (normal range: <10 mg/L), indicating that the infection may not be fully controlled. Renal function is monitored closely due to the nephrotoxic potential of vancomycin, with serum creatinine levels slightly elevated at 1.5 mg/dL (normal range: 0.6-1.2 mg/dL), necessitating adjustments in dosing and hydration status. Given these findings, the healthcare team revisits the timing and necessity of surgical intervention, weighing the risks of further delay against the potential benefits of immediate debridement.

In light of these developments, the team also explores additional supportive measures. Nutritionists recommend enhancing the patient's protein intake to support wound healing and immune function, while psychologists address the emotional impact of the prolonged recovery process, offering strategies to manage anxiety and promote resilience. This holistic approach underscores the importance of integrating medical, surgical, and psychosocial care in managing complex post-operative complications. The team's ongoing communication and collaboration remain pivotal as they prepare for the next steps in the patient's journey, ensuring that any further complications are anticipated and managed swiftly to optimize outcomes.